Skip to main content
. 2023 Jun;29(6):1162–1172. doi: 10.3201/eid2906.230130

Figure 3.

Figure 3

Selection of SARS-CoV-2 cases positive by PCR and of negative controls for analysis of vaccine effectiveness, Western Australia, Australia, February 1–May 31, 2022. IRSAD, Index of Relative Socioeconomic Advantage and Disadvantage.